Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells

  • Astorga-Gamaza, Antonio|||0000-0002-1276-5276
  • Vitali, Michele|||0000-0001-8618-8988
  • Borrajo, Mireya L.
  • Suárez-López, Rosa
  • Jaime, Carlos|||0000-0002-9690-9053
  • Bastús, Neus G.|||0000-0002-3144-7986
  • Serra-Peinado, Carla|||0000-0003-1413-3990
  • Luque-Ballesteros, Laura|||0000-0001-9515-5889
  • Blanch-Lombarte, Oscar|||0000-0002-8317-7535
  • Prado, Julia G.|||0000-0002-5439-4645
  • Lorente Guerrero, Juan|||0000-0002-3264-0251
  • Pumarola, Felix|||0000-0002-7914-1695
  • Pellicer, Marc
  • Falcó, Vicenç|||0000-0001-9626-0023
  • Genescà Ferrer, Meritxell|||0000-0001-6413-3812
  • Puntes, Víctor|||0000-0001-8996-9499
  • Buzón, Maria José|||0000-0003-4427-9413
HIV represents a persistent infection which negatively alters the immune system. New tools to reinvigorate different immune cell populations to impact HIV are needed. Herein, a novel nanotool for the specific enhancement of the natural killer (NK) immune response towards HIV-infected T-cells has been developed. Bispecific Au nanoparticles (BiAb-AuNPs), dually conjugated with IgG anti-HIVgp120 and IgG anti-human CD16 antibodies, were generated by a new controlled, linker-free and cooperative conjugation method promoting the ordered distribution and segregation of antibodies in domains. The cooperatively-adsorbed antibodies fully retained the capabilities to recognize their cognate antigen and were able to significantly enhance cell-to-cell contact between HIV-expressing cells and NK cells. As a consequence, the BiAb-AuNPs triggered a potent cytotoxic response against HIV-infected cells in blood and human tonsil explants. Remarkably, the BiAb-AuNPs were able to significantly reduce latent HIV infection after viral reactivation in a primary cell model of HIV latency. This novel molecularly-targeted strategy using a bispecific nanotool to enhance the immune system represents a new approximation with potential applications beyond HIV.